Elevating cGMP Manufacturing
At BioCina, we specialise in cGMP clinical and commercial manufacturing across a spectrum of modalities, including microbial, pDNA, mRNA drug substance as well as sterile, high potent and cytotoxic products. When it’s time for you to scale-up or manufacture for commercial supply, we have the capabilities you need to reach the next milestone. From pre-clinical through to commercial manufacturing scales, our state-of-the-art facilities are equipped to deliver your program on-time and in-full every time. With our commitment to industry-leading operational excellence and unwavering dedication to regulatory compliance, BioCina is the choice for an elevated manufacturing experience.
Where Experience Meets Advanced Infrastructure
BioCina is ready to support your evolving needs, with an expert team and state-of-the-art facilities, that serve our clients from early-stage development to full-scale commercial manufacturing. Our cGMP manufacturing capabilities span a wide range of manufacturing platforms, scales and technologies. Our cGMP manufacturing processes are underpinned by robust contamination control and multiproduct processing strategies that ensure the highest quality cGMP products for our clients. Entrust your program with BioCina, where experience and advanced infrastructure converge to meet your unique demands.
Comprehensive Manufacturing Services for All Phases
BioCina’s expertise covers every phase of your journey. We offer customised services from technology transfer, to process development, to clinical and commercial manufacturing. Count on BioCina to fulfill your clinical and commercial manufacturing requirements in our US FDA approved cGMP manufacturing facilities.
cGMP Equipment and Technology to Meet Your Needs
BioCina’s state-of-the-art cGMP facility is equipped to deliver highest quality microbial products:
Manufacturing for Your Biologics Needs
Microbial
Featuring a hybrid manufacturing model with both stainless steel and single-use fermenter systems for DS production, in a single highly integrated facility.
Plasmid DNA
cGMP manufacturing capabilities go up to 500 L, cell lysis and downstream processing equipment customed-scaled to meet your clients needs.
mRNA
End-to-end cGMP manufacturing of LNP encapsulated mRNA, including cell line development and cGMP manufacture of template plasmid DNA.
LNP
Lipid Nanoparticle (LNP) encapsulation services offering can support a wide range of applications.
Drug Product
Development, formulation, and analytical services for sterile liquids, clinical and commercial fill and finish manufacturing for small molecules and biologics.